Showing results (1741-1750 of 3,507) with videos related to

Sort By:
Pageof 351
Eclinicalmedicine|May 17, 2021
The relationship of large city out-of-hospital cardiac arrests and the prevalence of COVID-19Kevin E McVaney, Paul E Pepe, Lauren M Maloney, et al.
Eclinicalmedicine|May 17, 2021
Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysisThinley Dorji, Tanawin Nopsopon, Saran Tenzin Tamang, et al.
Eclinicalmedicine|May 17, 2021
Residential racial segregation and social distancing in the United States during COVID-19Alexandre White, Lingxin Hao, Xiao Yu, et al.
Eclinicalmedicine|May 17, 2021
Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell CarcinomaNicolas Bertrand, Pierre Guerreschi, Nicole Basset-Seguin, et al.
Eclinicalmedicine|May 17, 2021
Dysglycemia in adults at risk for or living with non-insulin treated type 2 diabetes: Insights from continuous glucose monitoringSouptik Barua, Ashutosh Sabharwal, Namino Glantz, et al.
Eclinicalmedicine|May 17, 2021
Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort studyA Schauwvlieghe, A Dunbar, E Storme, et al.
Eclinicalmedicine|May 3, 2021
Mumbai mayhem of COVID-19 pandemic reveals important factors that influence susceptibility to infectionRadha Yadav, Arup Acharjee, Akanksha Salkar, et al.
Eclinicalmedicine|May 3, 2021
An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-CAmaro Nunes Duarte-Neto, Elia Garcia Caldini, Michele Soares Gomes-Gouvêa, et al.
Eclinicalmedicine|May 3, 2021
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacyLaith J Abu-Raddad, Hiam Chemaitelly, Peter Coyle, et al.
Eclinicalmedicine|May 3, 2021
Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortalityFardad Haghpanah, Gary Lin, Simon A Levin, et al.
Pageof 351